SHR-1701

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

27 regulatory and trial events tracked for SHR-1701, covering 2021-05-12 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: PD1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer [Phase 2]

See pricing